Entera Bio reveals data for oral GLP-2 peptide for short bowel syndrome patientsEntera Bio has revealed positive pharmacokinetic results from its collaborative research combining a proprietary long acting GLP-2...
Dose-dependent link between the use of semaglutide and liraglutide injectables and body contouring procedures2 days ago